← Back to Screener
P3 Health Partners Inc. Common Stock (PIII)
Price$2.83
Favorite Metrics
Price vs S&P 500 (26W)-80.33%
Price vs S&P 500 (4W)-19.84%
Market Capitalization$18.75M
All Metrics
Book Value / Share (Quarterly)$13.60
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)11.61%
Cash Flow / Share (Quarterly)$-27.80
Price vs S&P 500 (YTD)-29.64%
Gross Margin (TTM)-4.12%
Net Profit Margin (TTM)-10.14%
EPS (TTM)$-45.20
10-Day Avg Trading Volume0.03M
EPS Excl Extra (TTM)$-45.20
Revenue Growth (5Y)24.62%
EPS (Annual)$-45.26
ROI (Annual)-58.87%
Gross Margin (Annual)-4.12%
Net Profit Margin (5Y Avg)-14.81%
Cash / Share (Quarterly)$7.61
Revenue Growth QoQ (YoY)3.81%
ROA (Last FY)-22.53%
Revenue Growth TTM (YoY)-2.76%
EBITD / Share (TTM)$-55.63
ROE (5Y Avg)-1098.22%
Operating Margin (TTM)-18.53%
Cash Flow / Share (Annual)$-27.77
P/B Ratio0.42x
P/B Ratio (Quarterly)1.02x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)0.18x
Net Interest Coverage (TTM)-4.83x
ROA (TTM)-20.72%
EPS Incl Extra (Annual)$-45.26
Current Ratio (Annual)0.24x
Quick Ratio (Quarterly)0.22x
3-Month Avg Trading Volume0.06M
52-Week Price Return-73.44%
Revenue / Employee (TTM)$4
Tangible BV / Share (Quarterly)$-4.38
P/S Ratio (Annual)0.01x
Asset Turnover (Annual)2.22x
52-Week High$11.30
Operating Margin (5Y Avg)-46.27%
EPS Excl Extra (Annual)$-45.26
26-Week Price Return-71.58%
Quick Ratio (Annual)0.22x
13-Week Price Return-12.75%
Total Debt / Equity (Annual)2.04x
Current Ratio (Quarterly)0.24x
Enterprise Value$267.153
Revenue / Share Growth (5Y)107.26%
Asset Turnover (TTM)2.04x
Revenue / Employee (Annual)$4
Pretax Margin (Annual)-22.00%
Cash / Share (Annual)$7.61
3-Month Return Std Dev158.13%
Gross Margin (5Y Avg)-1.95%
Net Income / Employee (TTM)$-0
ROE (Last FY)-178.90%
Net Interest Coverage (Annual)-4.83x
EPS Basic Excl Extra (Annual)$-45.26
Receivables Turnover (TTM)13.65x
Total Debt / Equity (Quarterly)4.10x
EPS Incl Extra (TTM)$-45.20
Receivables Turnover (Annual)13.65x
ROI (TTM)-61.67%
P/S Ratio (TTM)0.01x
Pretax Margin (5Y Avg)-47.51%
Revenue / Share (Annual)$446.34
Tangible BV / Share (Annual)$-17.92
Price vs S&P 500 (52W)-108.54%
Year-to-Date Return-25.50%
5-Day Price Return10.17%
EPS Normalized (Annual)$-45.26
ROA (5Y Avg)-16.80%
Net Profit Margin (Annual)-10.14%
Month-to-Date Return-15.58%
Cash Flow / Share (TTM)$-7.38
EBITD / Share (Annual)$-55.63
Operating Margin (Annual)-18.53%
LT Debt / Equity (Annual)1.18x
ROI (5Y Avg)-110.68%
LT Debt / Equity (Quarterly)2.29x
EPS Basic Excl Extra (TTM)$-45.20
P/B Ratio (Annual)1.06x
Pretax Margin (TTM)-22.00%
Book Value / Share (Annual)$23.31
Price vs S&P 500 (13W)-15.62%
Beta0.50x
Revenue / Share (TTM)$444.71
ROE (TTM)-191.97%
52-Week Low$1.52
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.00
4.00
4.00
4.00
Industry Peers — Health Services(13)
| Symbol | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|
PIIIP3 Health Partners Inc. Common Stock | — | -2.76% | -18.53% | -191.97% | $2.83 |
PRVAPrivia Health Group, Inc. Common Stock | 131.66x | 22.26% | 1.61% | 3.29% | $24.08 |
LFSTLifeStance Health Group, Inc. Common Stock | 277.93x | -12.76% | 2.07% | 0.65% | $6.92 |
WGSGeneDx Holdings Corp. Class A Common Stock | — | 39.97% | -3.06% | -7.41% | $69.71 |
USPHUS Physical Therapy Inc | 28.66x | 16.33% | 11.08% | 8.00% | $75.72 |
INNVInnovAge Holding Corp. Common Stock | — | 13.48% | 1.01% | 2.66% | $7.95 |
PNTGThe Pennant Group, Inc. Common Stock | 36.33x | 36.31% | 5.47% | 9.31% | $29.64 |
TALKTalkspace, Inc. Common Stock | 111.06x | 22.00% | 1.38% | 6.89% | $5.18 |
OMDAOmada Health, Inc. Common Stock | — | — | -5.41% | -7.10% | $14.04 |
SRTAStrata Critical Medical, Inc. Class A Common Stock | 9.61x | -3.02% | -10.18% | 16.45% | $4.52 |
DCGODocGo Inc. Common Stock | 3.28x | -47.74% | -56.81% | -71.45% | $0.68 |
About
P3 Health Partners is a population health management company that coordinates care delivery across networks of community-based healthcare providers. The company aggregates existing healthcare resources to facilitate integrated, coordinated care aimed at improving patient outcomes and reducing costs. Its physician-led model aligns providers around shared quality and cost metrics.